VDx THEMIS™ – Multi-Cancer Early Detection

VDx THEMIS™ – Multi-Cancer Early Detection

Specimen: Plasma (cfDNA)

Technology: Whole methylome sequencing + fragmentomics + CNV analysis

Performance: - AUC up to 0.96 - Stage I–II sensitivity ~73% - Specificity 99%